{"company": {"org_id": "T000378020", "org_name_cn": "上海谊众药业股份有限公司", "org_short_name_cn": "上海谊众", "org_name_en": "Shanghai Yizhong Pharmaceutical Co.,Ltd.", "org_short_name_en": "SHANGHAI YIZHONG", "main_operation_business": "抗肿瘤创新药及相关产品的开发。", "operating_scope": "　　许可项目：药品生产。（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：从事医疗、医药、医疗器械科技领域内技术开发、技术咨询、技术服务。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。", "district_encode": "310120", "org_cn_introduction": "上海谊众药业股份有限公司的主营业务是抗肿瘤创新药及相关产品的开发。公司的主要产品是抗肿瘤2类新药“注射用紫杉醇聚合物胶束”。", "legal_representative": "周劲松", "general_manager": "周劲松", "secretary": "方舟", "established_date": 1252512000000, "reg_asset": 206703640.0, "staff_num": 375, "telephone": "86-21-37190005", "postcode": "201401", "fax": "86-21-37190005-8037", "email": "info@yizhongpharma.com", "org_website": "www.yizhongpharma.com", "reg_address_cn": "上海市奉贤区仁齐路79号", "reg_address_en": null, "office_address_cn": "上海市奉贤区仁齐路79号", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1631116800000, "provincial_name": "上海市", "actual_controller": "周劲松 (20.84%)", "classi_name": "民营企业", "pre_name_cn": "上海谊众生物技术有限公司", "chairman": "周劲松", "executives_nums": 9, "actual_issue_vol": 26450000.0, "issue_price": 38.1, "actual_rc_net_amt": 936030479.0, "pe_after_issuing": null, "online_success_rate_of_issue": 0.02597431, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}}